HF10 therapy promises to substantially impact the management of back and leg pain with broad applicability to patients, physicians, and payers.
No takes yet. Share an insight, caveat, or question.
Kapural et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: